The University of Surrey, one of the UK's leading professional, scientific and technological universities and ZEUS Scientific, a United States based global in vitro diagnostics company, announced...
Aterovax SA, a private French diagnostics company focused on the development and commercialization of novel cardiovascular diagnostics and ZEUS Scientific, a United States based global in vitro...
ZEUS Scientific announces it has received clearance from the U.S. Food and Drug Administration (FDA) to market the ZEUS ELISA™ Borrelia VIsE-1/pepC10 IgG/IgM Test System, product code 3Z9661. This new...
Which method of ANA screening to use in clinical laboratories has been a matter of significant debate in many countries for several years now. Laboratories and physicians are divided between IFA,...
Chantilly, Virginia, Jan. 17, 2012 – Dynex Technologies announced today it has finalized a supply agreement with ZEUS Scientific Inc. (Branchburg, NJ), allowing ZEUS to utilize SmartKit™ packaging in...
Take the guide from your desktop to a number of mobile Apple devices ...
Gamma Therapeutics, Inc., an Oregon early stage biotechnology venture developing cardiovascular disease diagnostic tests, surgical therapy and military medicine solutions, announced today that it has...
Branchburg, NJ– December 27, 2011 – ZEUS Scientific Inc. announces it has received clearance from the U.S. Food and Drug Administration (FDA) to market the ZEUS ELISA Cardiolipin IgG/IgM/IgA Test...
ZEUS Scientific Inc. announces it has received clearance from the U.S. Food and Drug Administration (FDA) to market the ZEUS ELISA HSV gG-2 IgG Test System (product number 9Z9781G). This new Test...
ZEUS Scientific Inc. announces it has received clearance from the U.S. Food and Drug Administration (FDA) to market the ZEUS ELISA HSV gG-1 IgG Test System (product number 9Z9761G). This new Test...
ZEUS Scientific Inc. announced it has received clearance from the U.S. Food and Drug Administration (FDA) to market the ZEUS ELISA Treponema pallidum IgG Plus Test System. This new Test System is...
ZEUS Scientific Inc. is pleased to announce it has obtained CE Marking for the AtheNA Multi-Lyte® MMRV IgG Plus Test System (catalog number A93101G). The results from this Test System are intended for...
ZEUS Scientific Inc. announced it has received clearance from the U.S. Food and Drug Administration (FDA) to market the AtheNA Multi-Lyte® Treponema pallidum IgG Plus Test System. This new Test System...
ZEUS Scientific, Inc. announced it has received clearance from the U.S. Food and Drug Administration (FDA) to market the AtheNA Multi-Lyte® ToRCH IgG Plus Test System. This new Test System is intended...
ZEUS Scientific, Inc. announced it has received clearance from the U.S. Food and Drug Administration (FDA) to market the AtheNA Multi-Lyte® Borrelia VlsE-1 IgG/pepC10 IgM Plus Test System. This new...
ZEUS Scientific, Inc. is pleased to announce CE marking of the ZEUS ELISA Treponema pallidum (syphilis) IgG Test System. ...
ZEUS Scientific, Inc. today announced its intention to offer a rapid nasal screening test for methicillin-resistant Staphylococcus aureus (MRSA). The test is based upon ZEUS' own proprietary...
ZEUS Scientific, Inc. is pleased to announce the availability of the AIMS (Automated Immunoassay Multiplexing System) platform. ...